Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.7B |
| Sales growthchange from the year before | +6.5% |
| Net marginshare of sales kept as profit | 104.6% |
| Return on equityprofit vs. shareholders' accounting value | 9.0% |
| Debt / equitydebt vs. shareholders' accounting value | 0.49 |
| Change in share countnegative = the company is buying back its shares | +16.7% |
1 insider sold $569K on the open market.
| Ramani MohitChief Risk Officer | SoldJul 22 | 25,000 shat $22.74 · $569K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy